The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028.
Drug shortage crisis across the world, benefits associated with compounded medications, and increasing adoption of customized medicine (Personalized medicine) are among the major factors fueling the market growth.Moreover, growing demand for compounding pharmacy during COVID-19 are expected to foster the market growth during the forecast period.
However, product recalls and stringent regulatory requirements hinder the growth of the compounding pharmacies market.
The global compounding pharmacies market is segmented on the basis of product and therapeutic area.Based on product, the market is segmented into oral medications, topical medications, suppositories, and others.
The oral medications segment held the largest share of the market in 2020.The growth can be attributed to factors such as it is easy to consume and they come in different forms like solid tablets, capsules, chewable tablets, or lozenges that are easy to be swallowed whole or sucked or as drinkable liquids such as syrups, drops or solutions.
Further, the compounding pharmacies market for topical medications segment is expected to grow at the fastest CAGR during 2021–2028.Based on therapeutic area, the compounding pharmacies market is segmented into pain medications, hormone replacement therapies, dermatological applications, and others.
The pain medications segment held the largest share of the market in 2020. Moreover, the same segment is estimated to register the highest CAGR in the market during the forecast period.
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the National Health Service (NHS) are among the primary and secondary sources referred to while preparing the report on the compounding pharmacies market.
.
Our reports have been used by over 10K customers, including:
266 pages •
By The Business Research Company
• Jul 2022
Photodynamic Therapy Global Market Opportunities And Strategies To 2031: COVID-19 Implications And Growth provides the strategists; marketers and senior management with the critical information they need to assess the global photodynamic therapy market as it emerges from the COVID 19 shut down. Description: Where...
276 pages •
By The Business Research Company
• Jul 2022
Coronavirus (COVID-19) Current Therapy Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery provides the strategists; marketers and senior management with the critical information they need to assess the global coronavirus (COVID-19) current therapy market as it emerges from the COVID-19 shut down. Description: Where...
242 pages •
By The Business Research Company
• Jun 2022
Coronavirus (COVID-19) Current Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists; marketers and senior management with the critical information they need to assess the global coronavirus (COVID-19) current therapy market as it emerges from the COVID 19 shut down. Description: Where...
The idiopathic pulmonary fibrosis market is estimated to be USD 3,669.25 million in 2021 and it is expected to reach USD 5,723.69 million by 2027, registering a CAGR of 7.55% from 2022 to 2027. Severe coronavirus disease 2019 (COVID-19) affects the respiratory system and develops into respiratory failure. Patients with pre-existing...
241 pages •
By The Business Research Company
• Jul 2022
Microbiome Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global microbiome market as it emerges from the COVID-19 shutdown. Description: Where is the largest and fastest growing market for microbiome?...
The Digital Therapeutics market in the U.S. is expected to grow at a CAGR of 33.15% during 2022-2027 The following factors are likely to contribute to the growth of the U.S. digital therapeutics market: • Rise in Chronic Diseases and Need for Controlling Healthcare Costs • Increase in Adoption of Healthcare Applications...
The non-alcoholic steatohepatitis (NASH) market is projected to reach US$ 24,266.81 million by 2028 from US$ 1,631.92 million in 2021; it is expected to grow at a CAGR of 47.1% from 2021 to 2028. Major factors driving the non-alcoholic steatohepatitis (NASH) market growth include the rising prevalence of NASH and increasing initiatives...
The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development &...
The global radiotherapy market is valued at USD 6.3 billion in 2022 and is expected to reach USD 8.1 billion by 2027, at a CAGR of 5.1% during the forecast period. Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market. Additionally, growing awareness of the benefits...
MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing...
Therapy
World
North America
Europe
APAC
Health Expenditure
Cancer Incidence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.